BioPharmX Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
2
BioPharmX General Information
Description
BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated with drug therapies or drug delivery approaches that are sub-optimal. The company has developed its product portfolio using its proprietary drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. Its products include VI2OLET iodine dietary supplement, two clinical-stage product candidates, BPX01 and BPX03 and one development-stage product candidate, BPX02.
Contact Information
Website
www.biopharmx.comCorporate Office
- 900 E. Hamilton Avenue
- Suite 100
- Campbell, CA 95008
- United States
Corporate Office
- 900 E. Hamilton Avenue
- Suite 100
- Campbell, CA 95008
- United States
BioPharmX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioPharmX Comparisons
Industry
Financing
Details
BioPharmX Competitors (14)
One of BioPharmX’s 14 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Almirall | Corporation | Barcelona, Spain | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Aprecia | Formerly VC-backed | Mason, OH | ||||
| Cumberland Pharmaceuticals | Formerly VC-backed | Nashville, TN |
BioPharmX Patents
BioPharmX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019164984-A1 | Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics | Inactive | 20-Feb-2018 | ||
| WO-2018204711-A1 | Magnesium chloride composition for dermatological use | Inactive | 03-May-2017 | ||
| US-20170304359-A1 | Oral iodine dosage form | Inactive | 21-Apr-2016 | ||
| WO-2017185060-A1 | Oral iodine dosage form | Inactive | 21-Apr-2016 | ||
| ES-2846882-T3 | Pharmaceutical composition of tetracycline for dermatological use | Active | 23-Mar-2015 | A61K9/0014 |
BioPharmX Signals
BioPharmX Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioPharmX Acquisitions (2)
BioPharmX’s most recent deal was a Reverse Merger with Trex Wind Down. The deal was made on 18-May-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Trex Wind Down | 18-May-2020 | Reverse Merger | Pharmaceuticals | ||
| Thompson Designs (Nevada) | 23-Jan-2014 | Merger/Acquisition | Other Commercial Products |
BioPharmX Exits (1)
BioPharmX’s most recent exit was on 18-May-2020 from Trex Wind Down. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Trex Wind Down | 18-May-2020 | Completed |
|
BioPharmX FAQs
-
When was BioPharmX founded?
BioPharmX was founded in 2010.
-
Where is BioPharmX headquartered?
BioPharmX is headquartered in Campbell, CA.
-
What is the size of BioPharmX?
BioPharmX has 3 total employees.
-
What industry is BioPharmX in?
BioPharmX’s primary industry is Drug Delivery.
-
Is BioPharmX a private or public company?
BioPharmX is a Private company.
-
What is BioPharmX’s current revenue?
The current revenue for BioPharmX is .
-
How much funding has BioPharmX raised over time?
BioPharmX has raised $36.4M.
-
Who are BioPharmX’s investors?
Korea Investment Partners, Thompson Designs (Nevada), and Vivo Capital have invested in BioPharmX.
-
Who are BioPharmX’s competitors?
Charles River Laboratories International, Almirall, Intas Pharmaceuticals, Aprecia, and Cumberland Pharmaceuticals are some of the 14 competitors of BioPharmX.
-
When was BioPharmX acquired?
BioPharmX was acquired on 18-May-2020.
-
Who acquired BioPharmX?
BioPharmX was acquired by Trex Wind Down.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process